TP53 deletion is a recurring abnormality in AML, CLL, MDS, and plasma cell dyscrasia disorders including Plasma Cell Myeloma.
TP53 deletion is a poor cytogenetic risk factor across several disorders including AML, CLL, MDS and myeloma.
This test can be ordered individually or as part of a Plasma Cell Dyscrasia FISH Panel (See the individual panel test for more details).
Collect bone marrow aspirate in a sterile Sodium heparin (Na hep) syringe and transfer to a sterile vial/tube
- or -
Collect bone marrow in sterile syringe (non-heparinized) and transfer to a Dk green Sodium heparin (Na hep), no gel
Transfer aspirate from syringe to transport container.
Submit entire specimen unspun.
Bone marrow core:
Submit in sterile tube/cup filled with sterile culture medium, sterile Hanks Balance Salt Solution (HBSS) or sterile saline
or
Whole blood:
Whole Blood:
Immediately following collection, mix sample thoroughly by gently inverting 8 - 10, times to prevent clotting.
Submit entire specimen
AHL Cytogenetics oncology request
Ambient
Fluorescence in situ hybridization (FISH)
Normal or Abnormal with interpretation